BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20051848)

  • 1. Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension.
    Yogi A; O'Connor SE; Callera GE; Tostes RC; Touyz RM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):169-76. PubMed ID: 20051848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
    Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
    Benito M; Lorenzo M
    Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.
    Flamme I; von Reutern M; Drexler HC; Syed-Ali S; Risau W
    Dev Biol; 1995 Oct; 171(2):399-414. PubMed ID: 7556923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
    Mukherjee S; Tessema M; Wandinger-Ness A
    Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G; Clauss M; Risau W
    Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.
    Smith LE; Shen W; Perruzzi C; Soker S; Kinose F; Xu X; Robinson G; Driver S; Bischoff J; Zhang B; Schaeffer JM; Senger DR
    Nat Med; 1999 Dec; 5(12):1390-5. PubMed ID: 10581081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
    Wang C; Buck DC; Yang R; Macey TA; Neve KA
    J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.
    Whittles CE; Pocock TM; Wedge SR; Kendrew J; Hennequin LF; Harper SJ; Bates DO
    Microcirculation; 2002 Dec; 9(6):513-22. PubMed ID: 12483548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.